טוען...
Patient perceived changes in sexual dysfunction after initiation of natalizumab for multiple sclerosis
PURPOSE: Sexual dysfunction is a common but often overlooked secondary symptom of multiple sclerosis (MS) and can be associated with a decreased health-related quality of life (HRQoL). Natalizumab is a disease-modifying therapy approved for the treatment of relapsing forms of MS. In addition to its...
שמור ב:
| הוצא לאור ב: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6024530/ https://ncbi.nlm.nih.gov/pubmed/29977589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318781989 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|